American Restaurants Struggle with Reduced Sales Amid GLP-1 Weight-Loss Drug Use

This report highlights the challenges faced by American restaurants as the popularity of GLP-1 weight-loss drugs leads to fewer orders and increased operational costs. The trend of customers eating and drinking less while dining out is squeezing both large and small establishments financially.

Originally published by nyt